Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Delate

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Expert Opinion on Biological Therapy|October 10, 2025
Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritisAntony T-H Lin, Fang Niu, Rita L Hui, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 20, 2025
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapySean M McNary, Madalyn Kuhlenberg, Lucia F Basilio, et al.
Thrombosis Research|October 20, 2015
Thrombophilia testing patterns amongst patients with acute venous thromboembolismMelissa R Meyer, Daniel M Witt, Thomas Delate, et al.
Pharmacy Practice|July 6, 2019
Trends in high intensity statin use among secondary prevention patients 76 years and olderMichele Wood, Thomas Delate, Sheila L Stadler, et al.
Thrombosis Research|November 21, 2015
Assessment of algorithms to identify patients with thrombophilia following venous thromboembolismThomas Delate, Wendy Hsiao, Benjamin Kim, et al.
The Permanente Journal|December 21, 2013
Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attackKari L Olson, Lisa J Lash, Thomas Delate, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 25, 2023
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal CancerCatherine Pham, Fang Niu, Thomas Delate, et al.
Journal of Cardiovascular Pharmacology|February 16, 2023
Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor UseOlivia M Kim, Tatyana K Givens, Emily G Tang, et al.
Pharmacotherapy|October 27, 2011
Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressureKaren J McConnell, Jessica L Morris, Thomas Delate, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 30, 2015
Impact of a clinical pharmacy research team on pharmacy resident researchKari L Olson, Adriane N Irwin, Sarah J Billups, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Expert Opinion on Biological Therapy|October 10, 2025
Clinical and out-of-pocket cost outcomes after switching to biosimilar adalimumab-atto in patients with rheumatoid arthritisAntony T-H Lin, Fang Niu, Rita L Hui, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 20, 2025
Impact of cytochrome P-450 3A4 enzyme/P-glycoprotein inducing antiseizure medications on direct oral anticoagulant therapySean M McNary, Madalyn Kuhlenberg, Lucia F Basilio, et al.
Thrombosis Research|October 20, 2015
Thrombophilia testing patterns amongst patients with acute venous thromboembolismMelissa R Meyer, Daniel M Witt, Thomas Delate, et al.
Pharmacy Practice|July 6, 2019
Trends in high intensity statin use among secondary prevention patients 76 years and olderMichele Wood, Thomas Delate, Sheila L Stadler, et al.
Thrombosis Research|November 21, 2015
Assessment of algorithms to identify patients with thrombophilia following venous thromboembolismThomas Delate, Wendy Hsiao, Benjamin Kim, et al.
The Permanente Journal|December 21, 2013
Ambulatory treatment gaps in patients with ischemic stroke or transient ischemic attackKari L Olson, Lisa J Lash, Thomas Delate, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|September 25, 2023
Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal CancerCatherine Pham, Fang Niu, Thomas Delate, et al.
Journal of Cardiovascular Pharmacology|February 16, 2023
Real-World Outcomes of Proprotein Convertase Subtilisin Kexin-9 Inhibitor UseOlivia M Kim, Tatyana K Givens, Emily G Tang, et al.
Pharmacotherapy|October 27, 2011
Blood pressure level attainment among patients with coronary artery disease and uncontrolled blood pressureKaren J McConnell, Jessica L Morris, Thomas Delate, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 30, 2015
Impact of a clinical pharmacy research team on pharmacy resident researchKari L Olson, Adriane N Irwin, Sarah J Billups, et al.
Pageof 16